Sales & Marketing News | pharmaphorum

News

AZ's Truqap and Roche assay cleared for PTEN prostate cancer

AstraZeneca has claimed a second approval for AKT inhibitor Truqap, in prostate cancer, that should help achieve its blockbuster hopes for the drug.

News

UK approves Novo Nordisk's Wegovy pill

Novo Nordisk's fast-growing Wegovy pill has been approved in the UK for weight loss, its first European market.

News

Basketball great Shaq fronts Lilly sleep apnoea campaign

Eli Lilly has recruited basketball legend Shaquille O'Neal to promote a sleep apnoea awareness campaign and make the case for treatment with Zepbound.

News

Lilly wins new FDA approval for eczema drug Ebglyss

Lilly's Ebglyss has claimed an FDA approval for less-frequent maintenance dosing that could give it an edge over market leader Dupixent.

News

Bayer's asundexian starts EU review for ischaemic stroke

The EMA has started its review of Bayer's asundexian for secondary stroke prevention, keeping it ahead of a rival drug from BMS and J&J.

News

GSK pursues $10.6bn takeover of cancer biotech Nuvalent

GSK is preparing for its biggest acquisition in more than 10 years, agreeing to buy cancer drug developer Nuvalent for $10.6 billion.

AZ's Truqap and Roche assay cleared for PTEN prostate cancer

UK approves Novo Nordisk's Wegovy pill

Basketball great Shaq fronts Lilly sleep apnoea campaign

Lilly wins new FDA approval for eczema drug Ebglyss

Bayer's asundexian starts EU review for ischaemic stroke

GSK pursues $10.6bn takeover of cancer biotech Nuvalent

ESMO26: 'Unprecedented' results from DeLLphi-305 in SCLC

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks